All Studies | Orsiro US

Orsiro Clinical Studies

Filter

Study Name Sort descending	Study Type	Patients	Status	Primary Endpoint
BIO-RESORT	RCT	3,514	36-month FU available	TVF at 12 months
BIODEGRADE	RCT	3,850	Primary endpoint reached	TLF at 18 months
BIOFLOW-I	FIM	30	Completed, 12-month FU available	LLL at 9 months
BIOFLOW-II	RCT	452	Completed, 60-month FU available	LLL at 9 months
BIOFLOW-III	Single arm registry	1,356	Completed, 60-month FU available	TLF at 12 months
BIOFLOW-INDIA	Single arm registry	120	Completed	LLL at 9 months
BIOFLOW-IV	RCT	575	Completed, 60-month FU available	TVF at 12 months
BIOFlow-SV	Single arm registry	1,000	TBA	TLF at 12 months
BIOFLOW-V	RCT	1,334	36-month FU available	TLF at 12 months
BIOFLOW-VI	RCT	440	12-Month FU available	LLL at 9 months
BIOFLOW-VII	Single arm registry	556	Enrollment completed	TLF at 12 months
BIOLUX-RCT	RCT	210	12-month FU available	LLL at 6 months
BIONYX	RCT	2,488	24-month FU available	TVF at 12 months
BIOSCIENCE	RCT	2,119	Completed, 60-month FU available	TLF at 12 months
BIOSTEMI*	RCT	1,300	Primary endpoint reached	TLF at 12 months
ESODE	RCT	600	Enrolling	MACE at 12 months
HATTRICK-OCT	RCT	44	Primary endpoint reached	Strut coverage at 3 months
ISAR OCT	RCT	39	Primary endpoint reached	Strut coverage at 6 months
ORIENT	RCT	372	Primary endpoint reached	LLL at 9 months
SCAAR	All comers registry	69,570	-	24 months available
SMART-CHOICE	RCT	3,000	Primary endpoint reached	MACCE at 12 months
SORTOUT-IX	All comers RCT	3,151	Primary endpoint reached	TLF at 12 months
SORTOUT-VII	RCT	2,525	36-month FU available	TLF at 12 months